Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 28 Results

Title
Intervention Indication Therapeutic Area Year Actions
AZD3152 for preventing COVID-19 AZD3152 COVID-19 Infectious Disease 2023 View  |  Download
Baloxavir marboxil for reducing direct transmission of influenza Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2024 View  |  Download
Baloxavir marboxil for the post-exposure prevention of influenza in people aged 12 years and older Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2020 View  |  Download
Baloxavir marboxil for the treatment of influenza in patients aged 12 years and older and are at high risk of developing influenza complications Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2020 View  |  Download
Baloxavir marboxil for treating paediatric patients 1 to <12 years of age with influenza Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2021 View  |  Download
Baloxavir marboxil for treatment of influenza A or B infection in otherwise healthy patients aged 12 years and older Baloxavir marboxil (Xofluza; S-033188) Influenza Infectious Disease 2018 View  |  Download
Bulevirtide for chronic hepatitis delta virus infection Bulevirtide (Myrcludex B) Chronic hepatitis D Hepatology , Infectious Disease 2020 View  |  Download
Cabotegravir (long-acting injection) for prevention of HIV-1 infection Cabotegravir (GSK1265744) HIV-1 infection Infectious Disease 2023 View  |  Download
Cabotegravir (oral tablet) in combination with rilpivirine (oral tablet) for the short-term treatment of HIV-1 infection Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant) HIV-1 infection Infectious Disease 2019 View  |  Download
Cabotegravir in combination with rilpivirine long acting injection for the treatment of HIV-1 infection Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant) HIV-1 infection Infectious Disease 2019 View  |  Download
1 2 3
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications